<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00568217</url>
  </required_header>
  <id_info>
    <org_study_id>fs07hr</org_study_id>
    <secondary_id>K56721</secondary_id>
    <nct_id>NCT00568217</nct_id>
  </id_info>
  <brief_title>Antipyretics for Preventing Recurrences of Febrile Seizures</brief_title>
  <official_title>Antipyretics for Preventing Recurrences of Febrile Seizures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We wanted to find out if the early use of antipyretics is capable in preventing recurrences
      of febrile seizures. When a child has had his/her first febrile seizure, the parents were
      instructed to give him/her antipyretic medication every time when the child had a new episode
      of fever during two years.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 1997</start_date>
  <completion_date type="Actual">August 2005</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recurrence of febrile seizure</measure>
    <time_frame>two years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>we only had the primary outcome measure</measure>
    <time_frame>two years</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">231</enrollment>
  <condition>Recurrence of Febrile Seizure</condition>
  <arm_group>
    <arm_group_label>1 drug</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>diclofenac 15 mg/kg suppository once</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 drug</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo suppository once</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3 drug</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>acetaminophen mixture 15 mg/kg up to four times a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4 drug</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ibuprofen mixture 10 mg/kg up to four times a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 drug</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>oral placebo mixture up to four times a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac, Paracetamol, Ibuprofen</intervention_name>
    <description>Immediately if temperature &gt; 38 degree Celsius, diclofenac suppository 1,5 mg/kg once or placebo suppository After eight hours, if temperature still &lt; 38 degree Celsius, acetaminophen mixture 15 mg/kg up to four times a day, or ibuprofen mixture 10 mg/kg up to four times a day, or placebo mixture up to four times a day as long as temperature &lt; 38 degree Celsius</description>
    <arm_group_label>1 drug</arm_group_label>
    <arm_group_label>2 drug</arm_group_label>
    <arm_group_label>3 drug</arm_group_label>
    <arm_group_label>4 drug</arm_group_label>
    <arm_group_label>5 drug</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  First febrile convulsion

        Exclusion Criteria:

          -  Any prior convulsion or antiepileptic medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>4 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heikki Rantala, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oulu</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heikki Rantala</name>
      <address>
        <city>Oulu</city>
        <zip>90014</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2007</study_first_submitted>
  <study_first_submitted_qc>December 4, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2007</study_first_posted>
  <last_update_submitted>December 8, 2007</last_update_submitted>
  <last_update_submitted_qc>December 8, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2007</last_update_posted>
  <responsible_party>
    <name_title>Heikki Rantala, Professor</name_title>
    <organization>University of Oulu, Finland</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Recurrence</mesh_term>
    <mesh_term>Seizures</mesh_term>
    <mesh_term>Fever</mesh_term>
    <mesh_term>Seizures, Febrile</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Antipyretics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

